Riskpilot← Back to searchSign inGet full accessTBL MEDICAL AS
ASActiveOrg 9969377041 Etg Marken 32, 5017 BergenDay spa, sauna and steam bath activities · NACE 9623Est. 20119 employeeswww.tblmedical.no
Revenue 2024
NOK 11,1M
+25% vs 2023
EBITDA margin
6.1%
+321% vs 2023
Equity ratio
40.9%
Financial strength
Net profit 2024
NOK 496K
+718% vs 2023
| Revenue | NOK 11,1M | +25% |
| EBITDA | NOK 672K | +321% |
| Net profit | NOK 496K | +718% |
| Total assets | NOK 2,8M | +41% |
| Equity | NOK 1,2M | +75% |
| Employees | 9 | — |
Legal name
TBL MEDICAL AS
Org number
996937704
Legal form
Aksjeselskap
NACE code
9623 · Day spa, sauna and steam bath activities
Founded
19. mai 2011
Share capital
NOK 100 000
Employees
9 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder alene.
Company purpose
Tjenester innen helse, velværebehandling, hudbehandling, fjerning av tatovering/pigment og sykepleie oppdrag til private og offentlige helseforetak, samt hva hermed står i forbindelse.
Address
1 Etg Marken 32, 5017 Bergen
Phone
+4746426421
Email
info@tblmedical.no
Website
www.tblmedical.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 9 828 | 9 976 | 8 782 | 8 885 | 11 107 |
| Staff expenses | −4 332 | −5 304 | −4 505 | −4 685 | −4 636 |
| EBITDA | 1 280 | 590 | −249 | 160 | 672 |
| Depreciation & amort. | −622 | −699 | −310 | −240 | −36 |
| EBIT | 658 | −109 | −559 | −80 | 637 |
| Net financials | −96 | −84 | −48 | −17 | 3 |
| Profit before tax | 562 | −193 | −607 | −97 | 639 |
| Tax | 134 | −41 | −132 | −17 | 143 |
| Net profit | 428 | −152 | −475 | −80 | 496 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 4 468 | 4 789 | 2 310 | 1 997 | 2 826 |
| Equity | 1 368 | 1 216 | 741 | 661 | 1 157 |
| Long-term debt | 1 745 | 1 823 | 288 | 43 | 0 |
| Short-term debt | 1 355 | 1 750 | 1 281 | 1 293 | 1 669 |
| Total debt | 3 100 | 3 573 | 1 569 | 1 336 | 1 669 |
EBITDA margin
6.1%
This company
15.8%
Market median
-61% vs market
20202024
Equity ratio
40.9%
This company
38.2%
Market median
+7% vs market
20202024
Return on equity
42.9%
This company
18.4%
Market median
+133% vs market
20202024
Net profit margin
4.5%
This company
8.1%
Market median
-44% vs market
20202024
Asset turnover
3.93×
This company
1.12×
Market median
+251% vs market
20202024
Debt / equity
1.44×
This company
0.62×
Market median
-132% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
RB Chief Executive Officer | Chief Executive Officer | 2011 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2011 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 10% | 10% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
TBL MEDICAL AS 
CLEAR INK ASBoard members of TBL MEDICAL AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Rebecca Bergetun | Chief Executive Officer | 0 companies |
| Jimmy Walther Bergetun | Chairman | 0 companies |